Nuklearmedizin - NuclearMedicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q3 | 30.9% | 0.277 | Q3 | 40.6% |
| 2024 | 1.2 | Q4 | 24.3% | 0.281 | Q3 | 43.6% |
| 2023 | 1.0 | Q4 | 22.5% | 0.246 | Q3 | 42.4% |
| 2022 | 1.5 | Q4 | 32.7% | 0.253 | Q3 | 45.3% |
| 2021 | 2.2 | Q3 | 50.3% | 0.269 | Q3 | 48.1% |
| 2020 | — | — | 0.329 | Q3 | 53.4% | |
| 2019 | — | — | 0.383 | Q3 | 59.8% | |
| 2018 | — | — | 0.415 | Q3 | 59.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2567-6407
ISSN
0029-5566
region
Western Europe
coverage
1959-2026